TNF Pharmaceuticals Statistics
Total Valuation
TNFA has a market cap or net worth of $3.75 million. The enterprise value is -$6.88 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TNFA has 2.76 million shares outstanding. The number of shares has increased by 52.29% in one year.
| Current Share Class | 2.76M |
| Shares Outstanding | 2.76M |
| Shares Change (YoY) | +52.29% |
| Shares Change (QoQ) | +6.13% |
| Owned by Insiders (%) | 3.01% |
| Owned by Institutions (%) | 1.36% |
| Float | 2.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.72 |
| Quick Ratio | 1.52 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -142.68% and return on invested capital (ROIC) is -42.75%.
| Return on Equity (ROE) | -142.68% |
| Return on Assets (ROA) | -31.01% |
| Return on Capital (ROIC) | -42.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.82M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.41% in the last 52 weeks. The beta is 2.54, so TNFA's price volatility has been higher than the market average.
| Beta (5Y) | 2.54 |
| 52-Week Price Change | -79.41% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 52.18 |
| Average Volume (20 Days) | 246,407 |
Short Selling Information
The latest short interest is 279,276, so 10.14% of the outstanding shares have been sold short.
| Short Interest | 279,276 |
| Short Previous Month | 291,893 |
| Short % of Shares Out | 10.14% |
| Short % of Float | 11.71% |
| Short Ratio (days to cover) | 4.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.38M |
| Pretax Income | -12.29M |
| Net Income | -28.92M |
| EBITDA | n/a |
| EBIT | -11.38M |
| Earnings Per Share (EPS) | -$13.34 |
Full Income StatementBalance Sheet
The company has $10.64 million in cash and $18,285 in debt, giving a net cash position of $10.62 million or $3.86 per share.
| Cash & Cash Equivalents | 10.64M |
| Total Debt | 18,285 |
| Net Cash | 10.62M |
| Net Cash Per Share | $3.86 |
| Equity (Book Value) | 17.06M |
| Book Value Per Share | 6.73 |
| Working Capital | 5.04M |
Full Balance SheetCash Flow
| Operating Cash Flow | -10.14M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.14M |
| FCF Per Share | -$3.68 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |